Skip to main content

Table 6 All studies reporting experience with the ultrasound-guided 8-gauge vacuum-assisted Mammotome® biopsy technique

From: A comprehensive evaluation of the 8-gauge vacuum-assisted Mammotome® system for ultrasound-guided diagnostic biopsy and selective excision of breast lesions

Authors

Year

Total number of procedures

8-Gauge

11-Gauge

Performed by

Stated method of interval follow-up (IFU)

Fine et al. [13]

2002

124

75

49

≥ 5 physicians

ultrasound and clinical exam at 6 months

Johnson et al. [14]

2002

101

not specified

not specified

not specified

mammography at 6 months

Fine et al. [16 ]

2003

216

127

89

≥ 5 physicians

ultrasound and clinical exam at 6 months

Carpentier et al. [23]

2005

42

24

18

2 physicians

ultrasound at 8 weeks, 6 months, and 12 months

Grady et al. [27]

2005

542

189#

353#

2 physicians

surgical excision in 47 of 52 patients evaluated for atypia

Sebag et al. [31]

2006

650

230*

420*

3 centers

ultrasound, mammography, and clinical exam at 6 and 12 months

Vargos et al. [32]

2006

210

169

41

not specified

clinical exam at time not specified

Xiao et al. [33]

2006

174

104§

70§

2 physicians

not specified

Povoski

2007

304

304

0

1 physician

ultrasound and mammography at a median IFU of 6 months

  1. IFU, Interval follow-up
  2. # Via a personal e-mail communication with Dr. Ian Grady (Redding, California) from April 23, 2007, it was estimated and verified by Dr. Grady that approximately 50% (approximately 189) of the 378 cases performed after July 2002 where done by the ultrasound-guided 8-gauge Mammotome® biopsy approach and approximately 50% (approximately 189) of the 378 cases performed after July 2002 where done by the ultrasound-guided 11-gauge Mammotome® biopsy approach. Therefore, including the 164 cases that were done by the ultrasound-guided 11-gauge Mammotome® biopsy approach before July 2002, it was estimated that overall a total of approximately 353 ultrasound-guided 11-gauge Mammotome® biopsy procedures were performed and approximately 189 ultrasound-guided 8-gauge Mammotome® biopsy procedures were performed.
  3. * Via a personal e-mail communication with Dr. Philippe Sebag (Lyon, France) from January 23, 2007, it was estimated and verified by Dr. Sebag that approximately 35% (approximately 230) of the 650 cases performed where done by the ultrasound-guided 8-gauge Mammotome® biopsy approach and approximately 65% (approximately 420) of the 650 cases performed were done by the ultrasound-guided 11-gauge Mammotome® biopsy approach.
  4. § Via a personal e-mail communication with Dr. Li Xiao (Changsha, China) from May 16, 2007, it was estimated and verified by Dr. Xiao that approximately 60% (approximately 104) of the 174 cases performed where done by the ultrasound-guided 8-gauge Mammotome® biopsy approach and approximately 40% (approximately 70) of the 174 cases performed were done by the ultrasound-guided 11-gauge Mammotome® biopsy approach.